These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

450 related items for PubMed ID: 29965975

  • 1. Use of the revised World Health Organization cluster survey methodology to classify measles-rubella vaccination campaign coverage in 47 counties in Kenya, 2016.
    Subaiya S, Tabu C, N'ganga J, Awes AA, Sergon K, Cosmas L, Styczynski A, Thuo S, Lebo E, Kaiser R, Perry R, Ademba P, Kretsinger K, Onuekwusi I, Gary H, Scobie HM.
    PLoS One; 2018; 13(7):e0199786. PubMed ID: 29965975
    [Abstract] [Full Text] [Related]

  • 2. Micro-planning in a wide age range measles rubella (MR) campaign using mobile phone app, a case of Kenya, 2016.
    Ismail A, Tabu C, Onuekwusi I, Otieno SK, Ademba P, Kamau P, Koki B, Ngatia A, Wainaina A, Davis R.
    Pan Afr Med J; 2017; 27(Suppl 3):16. PubMed ID: 29296151
    [Abstract] [Full Text] [Related]

  • 3. Cluster survey evaluation of a measles vaccination campaign in Jharkhand, India, 2012.
    Scobie HM, Ray A, Routray S, Bose A, Bahl S, Sosler S, Wannemuehler K, Kumar R, Haldar P, Anand A.
    PLoS One; 2015; 10(5):e0127105. PubMed ID: 26010084
    [Abstract] [Full Text] [Related]

  • 4. Status of coverage of MR vaccination, after supplementary immunization activities in a rural area of South India: a rapid immunization coverage survey.
    Newtonraj A, Vincent A, Selvaraj K, Manikandan M.
    Rural Remote Health; 2019 Sep; 19(3):5261. PubMed ID: 31529972
    [Abstract] [Full Text] [Related]

  • 5. Impact of a Measles and Rubella Vaccination Campaign on Seroprevalence in Southern Province, Zambia.
    Carcelen AC, Mutembo S, Matakala KH, Chilumba I, Mulundu G, Monze M, Mwansa FD, Moss WJ, Hayford K.
    Am J Trop Med Hyg; 2021 May 03; 104(6):2229-2232. PubMed ID: 33939639
    [Abstract] [Full Text] [Related]

  • 6. Evaluation of impact of measles rubella campaign on vaccination coverage and routine immunization services in Bangladesh.
    Uddin MJ, Adhikary G, Ali MW, Ahmed S, Shamsuzzaman M, Odell C, Hashiguchi L, Lim SS, Alam N.
    BMC Infect Dis; 2016 Aug 12; 16():411. PubMed ID: 27519586
    [Abstract] [Full Text] [Related]

  • 7. Measles and rubella vaccination coverage in Haiti, 2012: progress towards verifying and challenges to maintaining measles and rubella elimination.
    Tohme RA, François J, Wannemuehler K, Magloire R, Danovaro-Holliday MC, Flannery B, Cavallaro KF, Fitter DL, Purcell N, Dismer A, Tappero JW, Vertefeuille JF, Hyde TB.
    Trop Med Int Health; 2014 Sep 12; 19(9):1105-15. PubMed ID: 25041586
    [Abstract] [Full Text] [Related]

  • 8. Progress in measles and rubella elimination in Iran.
    Esteghamati A, Gouya MM, Zahraei SM, Dadras MN, Rashidi A, Mahoney F.
    Pediatr Infect Dis J; 2007 Dec 12; 26(12):1137-41. PubMed ID: 18043452
    [Abstract] [Full Text] [Related]

  • 9. Who gets vaccinated in a measles-rubella campaign in Nepal?: results from a post-campaign coverage survey.
    Danovaro-Holliday MC, Rhoda DA, Lacoul M, Prier ML, Gautam JS, Pokhrel TN, Dixit SM, Rajbhandari RM, Bose AS.
    BMC Public Health; 2022 Feb 03; 22(1):221. PubMed ID: 35114969
    [Abstract] [Full Text] [Related]

  • 10. Haiti 2007-2008 national measles-rubella vaccination campaign: implications for rubella elimination.
    Rainey JJ, Danovaro-Holliday MC, Magloire R, Kananda G, Lee CE, Chamouillet H, Lacapere F, Mung K, Luman ET.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S616-21. PubMed ID: 21954256
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of vaccination coverage of measles-rubella campaign in Imphal East District, Manipur: A cross-sectional study.
    Rajkumari B, Keisam A, Haobam DS, Thounaojam T.
    Indian J Public Health; 2020 Sep 01; 64(2):173-177. PubMed ID: 32584301
    [Abstract] [Full Text] [Related]

  • 12. Factors affecting non-coverage of measles-rubella vaccination among children aged 9-59 months in Tanzania.
    Mkopi A, Mtenga S, Festo C, Mhalu G, Shabani J, Tillya R, Masemo A, Kheir K, Nassor M, Mwengee W, Lyimo D, Masanja H.
    Vaccine; 2021 Oct 01; 39(41):6041-6049. PubMed ID: 34531077
    [Abstract] [Full Text] [Related]

  • 13. Research priorities for accelerating progress toward measles and rubella elimination identified by a cross-sectional web-based survey.
    Kriss JL, Grant GB, Moss WJ, Durrheim DN, Shefer A, Rota PA, Omer SB, Masresha BG, Mulders MN, Hanson M, Linkins RW, Goodson JL.
    Vaccine; 2019 Sep 10; 37(38):5745-5753. PubMed ID: 30898393
    [Abstract] [Full Text] [Related]

  • 14. A measles and rubella (MR) catch-up vaccination campaign in an Egyptian University: vaccine uptake and knowledge and attitudes of students.
    Abd Elaziz KM, Sabbour SM, Dewedar SA.
    Vaccine; 2010 Nov 03; 28(47):7563-8. PubMed ID: 20797454
    [Abstract] [Full Text] [Related]

  • 15. Nationwide campaign for vaccination of adults against rubella and measles--Costa Rica, 2001.
    Centers for Disease Control and Prevention (CDC).
    MMWR Morb Mortal Wkly Rep; 2001 Nov 09; 50(44):976-9. PubMed ID: 11724151
    [Abstract] [Full Text] [Related]

  • 16. Strengthening routine immunization through measles-rubella elimination.
    Biellik RJ, Orenstein WA.
    Vaccine; 2018 Sep 05; 36(37):5645-5650. PubMed ID: 30041881
    [Abstract] [Full Text] [Related]

  • 17. Serogroup A meningococcal conjugate (PsA-TT) vaccine coverage and measles vaccine coverage in Burkina Faso--implications for introduction of PsA-TT into the Expanded Programme on Immunization.
    Meyer SA, Kambou JL, Cohn A, Goodson JL, Flannery B, Medah I, Messonnier N, Novak R, Diomande F, Djingarey MH, Clark TA, Yameogo I, Fall A, Wannemuehler K.
    Vaccine; 2015 Mar 17; 33(12):1492-8. PubMed ID: 25636915
    [Abstract] [Full Text] [Related]

  • 18. Post-campaign coverage evaluation of a measles and rubella supplementary immunization activity in five districts in India, 2019-2020.
    Thangaraj JWV, Prosperi C, Kumar MS, Hasan AZ, Kumar VS, Winter AK, Bansal AK, Chauhan SL, Grover GS, Jain AK, Kulkarni RN, Sharma SK, Soman B, Chaaithanya IK, Kharwal S, Mishra SK, Salvi NR, Sarmah NP, Sharma S, Varghese A, Sabarinathan R, Duraiswamy A, Rani DS, Kanagasabai K, Lachyan A, Gawali P, Kapoor M, Chonker SK, Sangal L, Mehendale SM, Sapkal GN, Gupta N, Hayford K, Moss WJ, Murherkar MV.
    PLoS One; 2024 Mar 17; 19(3):e0297385. PubMed ID: 38551928
    [Abstract] [Full Text] [Related]

  • 19. Economic analysis of measles elimination program in the Republic of Korea, 2001: a cost benefit analysis study.
    Bae GR, Choe YJ, Go UY, Kim YI, Lee JK.
    Vaccine; 2013 May 31; 31(24):2661-6. PubMed ID: 23602654
    [Abstract] [Full Text] [Related]

  • 20. The use of rapid coverage monitoring in the national rubella vaccination campaign, Haiti 2007-2008.
    Lacapère F, Magloire R, Danovaro-Holliday MC, Flannery B, Chamoulliet H, Celestin EP.
    J Infect Dis; 2011 Sep 01; 204 Suppl 2():S698-705. PubMed ID: 21954269
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 23.